Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MDA Space Ltd T.MDA

Alternate Symbol(s):  MDALF

MDA Space Ltd, formerly MDA Ltd, is a global space company. The Company is a robotics, satellite systems and Geo intelligence provider. It provides communications satellites and earth and space observation. It is also involved in space exploration and infrastructure. Its software, AURORA, is a digital satellite product line providing critical new solutions to operators. AURORA technology... see more

TSX:MDA - Post Discussion

MDA Space Ltd > David Fawcett - Linkedin
View:
Post by Possibleidiot01 on Aug 09, 2024 4:05pm

David Fawcett - Linkedin

4 hours ago
 
 
: —' , !

Let's set the record straight: the big aerospace and defense companies are growing revenue at a steady mid-single-digit pace and are trading at around 15x EV/EBITDA. Meanwhile, MDA is projecting 30% revenue growth not just for this year, but consistently for the next five years—and it's trading at just 7x EV/EBITDA. This appears to be mispriced and presents a highly compelling investment opportunity.

Yet, the street seems fixated on cash flow, overlooking MDA’s robust growth potential. For the past three consecutive conference calls, 80-90% of analyst questions have zeroed in on working capital movements and cash flow ratios relative to growth capex. Sure, these are necessary questions, but the real story here is growth—not cash flow. For the love of God, it's time to refocus and dig into the validity of the growth!

When a CEO tells us they plan to grow 30% annually for the next five years, and the company is trading at a mere 7x EV/EBITDA, we categorize this as a "if this is true, this is a great opportunity.” Our research and due diligence are then focused on validating this growth trajectory, and after many calls with management, competitors, and clients, we believe the data backs it up. The growth was further reaffirmed in the quarter with the increased guidance implying nearly 30% in 2024, after growing 26% in 2023.

We’ve previously shared our thoughts on MDA’s growth prospects, so we won’t dive deep into that again here. But let's be clear: the story is not about this year's working capital movements. If MDA’s growth narrative plays out as projected, EBITDA could triple over the next five years, and the valuation multiple should also rise. That translates to a potential fivefold increase in stock price. That’s the real story.

It’s time for the street to ask the right questions and start recognizing the forest for the trees. MDA's growth potential is the headline, not cash flow minutiae.

hashtagsmallcaps hashtaghedgefunds hashtagtechnology hashtagspace
 


Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities